Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects
Clinical trial NCT02094521 · COMPLETED
Trial details
- NCT number
- NCT02094521
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.